Coeptis Therapeutics
(NASDAQ) COEP
Coeptis Therapeutics Financials at a Glance
Market Cap
$74.55M
Revenue (TTM)
$1.36M
Net Income (TTM)
$8.33M
EPS (TTM)
$-2.80
P/E Ratio
-4.28
Dividend
$0.00
Beta (Volatility)
0.45 (Low)
Dividend
$0.00
Beta (Volatility)
0.45 (Low)
Price
$12.02
Volume
127
Open
$11.77
Price
$12.02
Volume
127
Open
$11.77
Previous Close
$11.98
Daily Range
$11.77 - $12.25
52-Week Range
$6.26 - $21.41
Dividend
$0.00
Beta (Volatility)
0.45 (Low)
Price
$12.02
Volume
127
Open
$11.77
Previous Close
$11.98
Daily Range
$11.77 - $12.25
52-Week Range
$6.26 - $21.41
COEP News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Coeptis Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
6
CEO
David Mehalick
Website
www.coeptistx.comHeadquarters
Wexford, PA 15090, US
COEP Financials
Key Financial Metrics (TTM)
Gross Margin
-2%
Operating Margin
-10%
Net Income Margin
-6%
Return on Equity
-97%
Return on Capital
-72%
Return on Assets
-42%
Earnings Yield
-23.36%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$74.55M
Shares Outstanding
6.22M
Volume
127
Short Interest
0.00%
Avg. Volume
50.73K
Financials (TTM)
Gross Profit
$2.83M
Operating Income
$13.04M
EBITDA
$11.82M
Operating Cash Flow
$8.60M
Capital Expenditure
$0.00
Free Cash Flow
$8.60M
Cash & ST Invst.
$6.35M
Total Debt
$268.88K
Coeptis Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$862.05K
N/A
Gross Profit
$3.20M
-1130.1%
Gross Margin
-3.71%
N/A
Market Cap
$74.55M
N/A
Market Cap/Employee
$14.91M
N/A
Employees
5
N/A
Net Income
$1.58M
+47.6%
EBITDA
$2.29M
+14.5%
Quarterly Fundamentals
Net Cash
$6.08M
+802.2%
Accounts Receivable
$7.35K
N/A
Inventory
$0.00
N/A
Long Term Debt
$150.00K
-11.2%
Short Term Debt
$118.88K
-90.3%
Return on Assets
-41.98%
N/A
Return on Invested Capital
-72.17%
N/A
Free Cash Flow
$1.69M
-17.5%
Operating Cash Flow
$1.69M
-17.5%